News & Events

All the latest news and events from PhoreMost

PhoreMost appoints Christian Dillon as Vice President of Biology
14th June 2021

PhoreMost appoints Christian Dillon as Vice President of Biology

Appointment will play a leading role in progression of novel targets identified by PhoreMost’s proprietary SITESEEKER® platform toward drug discovery VP Biology will support across oncology, targeted protein degradation, and neurodegeneration therapeutic areas Cambridge, UK, 14 June 2021: PhoreMost Ltd. , the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’ disease targets …

PhoreMost and Boehringer Ingelheim enter multi-project drug discovery collaboration
7th January 2020

PhoreMost and Boehringer Ingelheim enter multi-project drug discovery collaboration

PhoreMost and Sentinel Oncology expand collaboration to jointly accelerate novel glioma therapeutic through preclinical development
4th November 2019

PhoreMost and Sentinel Oncology expand collaboration to jointly accelerate novel glioma therapeutic through preclinical development

PhoreMost named ‘Biotech Company of the Year’ at Cambridge Independent Science and Technology Awards 2019
31st October 2019

PhoreMost named ‘Biotech Company of the Year’ at Cambridge Independent Science and Technology Awards 2019

PhoreMost appoints Dr Lorenz Mayr as Non-Executive Director
15th July 2019

PhoreMost appoints Dr Lorenz Mayr as Non-Executive Director

PhoreMost and inStem enter structural biology alliance
8th July 2019

PhoreMost and inStem enter structural biology alliance

PhoreMost and C4X Discovery announce neurodegeneration focused drug discovery collaboration
25th June 2019

PhoreMost and C4X Discovery announce neurodegeneration focused drug discovery collaboration

No events currently available